Month-End Profit-Taking Weighs on Equities as the Euro Pops Above $1.11
Oxford Biomedica signs COVID-19 vaccine supply deal with AZ
The 6-Feet Social Distancing Rule Can Kill You – Think Cobras
COVID-19 Mouse CRISPR Engineered to Recapitulate Human COVID-19
Battling disease with ultraviolet light
Oxford Uni coronavirus vaccine ‘has 50% chance of success’
Public disclosure of COVID-19 cases is more effective than lockdowns
These Four Recreational Dividend Stocks Are Up Double Digits and More As We Come Out of Lockdown
Rebuilding Trust in Coronaworld
Some patients with bladder cancer ‘can’t wait’ for treatment during the COVID-19 pandemic
Nebraska researcher develops contact tracing technology
Mammoth Biosciences teams with GSK to put Covid-19 CRISPR tests at home, airports, borders
Using machine learning to estimate COVID-19’s seasonal cycle
Six feet not far enough to stop virus transmission in light winds
The ECB Has Been Hiding Risk. They Won't Be Able to Do It Much Longer.
Re-Opening Narratives Too Short-Term
Will PMIs Show Economies Hit Bottom? Are US-China Tensions Rising Again?
Using telehealth to transition diabetes inpatients to virtual care during COVID-19
Social Norms for the Era of Social Distancing
Skilled partners in the conduct of HIV prevention trials join COVID-19 response
Biotech’s Golden Moment
In victory over polio, hope for the battle against COVID-19
Merck CPO Julie Gerberding On The Deadliness Of Covid-19
UCF receives NSF RAPID Award to develop cough drops to help control COVID-19
New Information Trickling In Slowly
There is no magic bullet
What’s Needed to Build Pandemic Resilience and Move to Reopening?
States Experimenting – How Many Dollars Per COVID Death?
Gilead’s Remdesivir Receives Emergency FDA Approval; Here's What This Five-Star Analyst Has To Say
The Meat Supply Story